Macalinao ML, Inoue S-I, Tsogtsaikhan S, Matsumoto H, Bayarsaikhan G, Jian J-Y, Kimura K, Yasumizu Y, Inoue T, Yoshida H, Hafalla J, D Kimura, Yui K: IL-27 produced during acute malaria infection regulates Plasmodium-specific memory CD4+ T cells. EMBO Mol Med 15(12): e17713, 2023.
Ganley M, Holz LE, Minnell, JJ, de Menezes MN, Burn OK, Poa KCY, Draper SL, English K, Chan STS, Anderson RJ, Compton BeJ, Marshall A, Cozijnsen A, Chua YC, Ge Z, Farrand KJ, Mamum JC, Xu C, Cockburn IA, Yui K, Bertolino P, Gras S, Nours JL, Rossjohn J, Fernandez-Ruiz D, McFadden GI, Ackerley DF, Painter GF, Hermans IF, Heath WR: mRNA vaccine against malaria tailored for liver-resident memory T cells. Nature Immunol 24(9): 1487-1498, 2023.
Macalinao MLM, Fornace KM, Reyes RA, Medado IAP, Mercado ES, Bareng APN, Hall T, Adams JH, Huon C,E Chitis C, Luchvez JS, Tetteh KKA, Yui K, Hafalla JCR, Espino FEJ, Drakeley CJ: Analytical approaches for antimalarial antibody responses to confirm historical and recent malaria transmission: an example from the Philippines. Lancet Reg Health West Pac 37: 100792, 2023.
Tayama Y, Mizukami S, Toume K, Komatsu K, Yanagi T, Nara T, Tieu P, Huy NT, Hamano S, Hirayama K: Anti-Trypanosoma cruzi activity of Coptis rhizome extract and its constituents. Trop Med Health 51(1): 12, 2023.
Mizuta S, Mosaddeque F, Tun MMN, Teklemichael AA, Taniguchi M, Hosokawa M, Yamaguchi T, Makau J, Huy NT, Mizukami S, Nishida N, Morita K, Hirayama K: Challenges Based on Antiplasmodial and Antiviral Activities of 7-Chloro-4-aminoquinoline Derivatives. ChemMedChem 18(7): e202200586, 2023.
Kawaguchi M, Noda M, Ono A, Kamiya M, Matsumoto M, Tsurumaru M, Mizukami S, Mukai H, Kawakami S: Effect of Cholesterol Content of Lipid Composition in mRNA-LNPs on the Protein Expression in the Injected Site and Liver After Local Administration in Mice. J Pharm Sci 112(5): 1401-1410, 2023.
Mizoguchi I, Katahira Y, Inoue S, Sakamoto E, Watanabe A, Furusaka Y, Irie A, Senju S, Nishimura Y, Mizukami S, Hirayama K, Nakamura S, Eto K, Hasegawa H, Yoshimoto T: A novel coculture system for assessing respiratory sensitizing potential by IL-4 in T cells. ALTEX 40(2): 204-216, 2023.
2022
Ogawa K, Kato N, Yoshida M, Hiu T, Matsuo T, Mizukami S, Omata D, Suzuki R, Maruyama K, Mukai H, Kawakami S: Focused ultrasound/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain. J Control Release. 348:34-41, 2022.
Ngwe Tun MM, Luvai E, Nwe KM, Toume K, Mizukami S, Hirayama K, Komatsu K, Morita K: Anti-SARS-CoV-2 activity of various PET-bottled Japanese green teas and tea compounds in vitro. Arch Virol. 167(7):1547-1557, 2022.
Ngwe Tun MM, Toume K, Luvai E, Nwe KM, Mizukami S, Hirayama K, Komatsu K, Morita K: The discovery of herbal drugs and natural compounds as inhibitors of SARSCoV-2 infection in vitro. J Nat Med 76(2):402-409, 2022.
Hashim Y, Toume K, Mizukami S, Kitami T, Taniguchi M, Teklemichael AA, Tayama Y, Huy NT, Lami JN, Bodi JM, Hirayama K, Komatsu K: Phenylpropanoidconjugated iridoid glucosides from leaves of Morinda morindoides. J Nat Med 76(1):281-290, 2022.
Kamiya M, Matsumoto M, Yamashita K, Izumi T, Kawaguchi M, Mizukami S, Tsurumaru M, Mukai H, Kawakami S: Stability Study of mRNA-Lipid Nanoparticles Exposed to Various Conditions Based on the Evaluation between Physicochemical Properties and Their Relation with Protein Expression Ability. Pharmaceutics 14(11):2357, 2022.
Zhang LF, Lepenies B, Nakamae S, Young BM, Santos RL, Raffatellu M, Cobb BA, Hiyoshi H, Baumler AJ: The Vi Capsular Polysaccharide of Salmonella Typhi Promotes Macrophage Phagocytosis by Binding the Human C-Type Lectin DC-SIGN. mBio. 13(6):e0273322, 2022.
2021
Hashim Y, Toume K, Mizukami S, Ge YW, Taniguchi M, Teklemichael AA, Huy NT, Bodi JM, Hirayama K, Komatsu K: Phenylpropanoid conjugated iridoids with antimalarial activity from the leaves of Morinda morindoides. J Nat Med 75(4): 915-925, 2021.
Raini SK, Takamatsu Y, Dumre SP, Urata S, Mizukami S, Moi ML, Hayasaka D, Inoue S, Morita K, Ngwe Tun MM: The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection. Antiviral Res 192: 105121, 2021.
Nguyen PTV, Van Dat T, Mizukami S, Nguyen DLH, Mosaddeque F, Kim SN, Nguyen DHB, Ðinh OT, Vo TL, Nguyen GLT, Quoc Duong C, Mizuta S, Tam DNH, Truong MP, Huy NT, Hirayama K: 2D-quantitative structure-activity relationships model using PLS method for anti-malarial activities of anti-haemozoin compounds. Malar J 20(1): 264, 2021.
Tran L, Radwan I, Minh LHN, Low SK, Hashan MR, Gomaa MD, Abdelmongy M, Abdelaziz AI, Mohamed A, Tawfik GM, Mizukami S, Hirayama K, Huy NT: Role of cytokines produced by T helper immune-modulators in dengue pathogenesis: A systematic review and meta-analysis. Acta Trop 216: 105823, 2021.
2020
Manh DH, Weiss LN, Thuong NV, Mizukami S, Dumre SP, Luong QC, Thanh LC, Thang CM, Huu PT, Phuc LH, Nhung CTH, Mai NT, Truong NQ, Ngu VTT, Quoc DK, Ha TTN, Ton T, An TV, Halhouli O, Quynh LN, Kamel MG, Karbwang J, Huong VTQ, Huy NT, Hirayama K: Kinetics of CD4+ T Helper and CD8+ Effector T Cell Responses in Acute Dengue Patients. Front Immunol 11: 1980, 2020.
Pembi E, John S, Dumre SP, Ahmadu BU, Vuong NL, Ebied A, Mizukami S, Huy NT, Cuevas LE, Hirayama K: Impact of political conflict on tuberculosis notifications in North-east Nigeria, Adamawa State: a 7-year retrospective analysis. BMJ Open 10(9): e035263, 2020.
Iglesias Rodríguez IM, Mizukami S, Manh DH, Thuan TM, Justiniano HA, Miura S, Ito G, Huy NT, Smith C, Hirayama K: Knowledge, behaviour and attitudes towards Chagas disease among the Bolivian migrant population living in Japan: a cross-sectional study. BMJ Open 10(9): e032546, 2020.
Teklemichael AA, Mizukami S, Toume K, Mosaddeque F, Kamel MG, Kaneko O, Komatsu K, Karbwang J, Huy NT, Hirayama K: Anti-malarial activity of traditional Kampo medicine Coptis rhizome extract and its major active compounds. Malar J 19(1): 204, 2020.
2019
Vasquez Velasquez C, Russomando G, Espinola EE, Sanchez Z, Mochizuki K, Roca Y, Revollo J, Guzman A, Quironga B, Rios Morgans S, Vargas Oritz R, Zambrana Ortega A, Espinoza E, Nishizawa JE, Kamel MG, Kikuchi M, Mizukami S, Na-Banghachang K, Tien Huy N, Hirayama K：IL-17A, a possible biomarker for the evaluation of treatment response in Trypanosoma cruzi infected children: A 12-months follow-up study in Bolivia. PLoS Negl Trop Dis 25; 13(9): e0007715, 2019.
